Boston Scientific announces conference call discussing first quarter 2026 results
Boston Scientific (NYSE: BSX) will webcast a conference call to discuss its first quarter ended March 31, 2026 results on April 22, 2026 at 8:00 a.m. ET.
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will webcast a conference call to discuss its first quarter ended March 31, 2026 results on April 22, 2026 at 8:00 a.m. ET.
The call will be hosted by Mike Mahoney, chairman and CEO, and Jon Monson, EVP and CFO. A news release with results will be issued before the call; live webcast and replay available at the company's investor site.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BSX
On Mar 30, the day this news came out, BSX closed 9.02% below the previous close.
Data tracked by StockTitan Argus for the Mar 30 session.
Key Figures
- Earnings period end
- March 31, 2026
- First quarter 2026 reporting period referenced for upcoming call
- Earnings call date
- April 22, 2026
- Scheduled date for Q1 2026 results conference call
- Earnings call time
- 8:00 a.m. ET
- Start time of the Q1 2026 webcast conference call
- Replay availability
- ≈1 hour post-event
- Replay accessible about one hour after call completion
Previous Conferences,earnings Reports
-
Outlined JPM conference appearance and Q4/FY 2025 earnings call timing.
-
Announced 2025 Investor Day and Q3 2025 earnings conference call schedule.
-
Set date and time for Q2 2025 earnings call and webcast access.
-
Scheduled Q1 2025 results call with leadership and webcast details.
-
Announced JPM conference participation and Q4 2024 earnings call timing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2026-results-302727378.html
SOURCE Boston Scientific Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.